Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-2-6
|
pubmed:abstractText |
In an effort to develop new strategies for immunotherapy of metastatic renal cell carcinoma, we investigated the therapeutic potential of interleukin-4 in a visceral renal tumor using the murine Renca renal adenocarcinoma model. Renca cells were implanted underneath the renal capsule of Balb/c mice to induce a primary tumor that spontaneously metastasized to several organs. Established primary renal tumors 4 to 6 mm. in diameter were treated by intralesional administration of recombinant murine interleukin-4 (IL-4). This treatment caused a marked inhibition of the primary tumor growth but had little effect on the progression of metastases in the liver, mesentery and lungs. Immunohistochemistry studies performed on renal tumor sections showed a macrophage infiltration that became predominant 7 days after IL-4 treatment. CD8+ T cells were also observed at the periphery and within the tumor. These data suggest that IL-4 mediated a potent antitumor effect when administered intralesionally although its effects remained localized with no impact on metastases at distant sites. Interleukin-4 antitumor activity seems to be mediated by recruitment of macrophages and T cells in the tumor.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-5347
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
490-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7815631-Animals,
pubmed-meshheading:7815631-Cell Movement,
pubmed-meshheading:7815631-Female,
pubmed-meshheading:7815631-Injections, Intralesional,
pubmed-meshheading:7815631-Interleukin-4,
pubmed-meshheading:7815631-Kidney Neoplasms,
pubmed-meshheading:7815631-Macrophages,
pubmed-meshheading:7815631-Mice,
pubmed-meshheading:7815631-Mice, Inbred BALB C,
pubmed-meshheading:7815631-Recombinant Proteins,
pubmed-meshheading:7815631-T-Lymphocytes
|
pubmed:year |
1995
|
pubmed:articleTitle |
Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases.
|
pubmed:affiliation |
Department of Urology, Wayne State University School of Medicine, Detroit, Michigan 48201.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|